Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application.
Schiffelers LDJ, Tesfamariam YM, Jenster LM, Diehl S, Binder SC, Normann S, Mayr J, Pritzl S, Hagelauer E, Kopp A, Alon A, Geyer M, Ploegh HL, Schmidt FI.
Schiffelers LDJ, et al. Among authors: ploegh hl.
Nat Commun. 2024 Sep 26;15(1):8266. doi: 10.1038/s41467-024-52110-1.
Nat Commun. 2024.
PMID: 39327452
Free PMC article.